Development of a robust flow cytometry-based pharmacodynamic assay to detect phosphoprotein signals for phosphatidylinositol 3-kinase inhibitors in multiple myeloma.

Saved in:

Bibliographic Details
Title:	Development of a robust flow cytometry-based pharmacodynamic assay to detect phosphoprotein signals for phosphatidylinositol 3-kinase inhibitors in multiple myeloma.
Authors:	Congfen Li¹, Takahashi, Chikara¹, Zhang, Liangxuan¹, Huseni, Mahrukh¹, Stankovich, Basha², Mashhedi, Haider¹, Lee, Joanna¹, French, Dorothy¹, Anderson, Jeff Eastham¹, Kim, Doris¹, Howell, Kathy¹, Brauer, Matthew J.¹, Kowanetz, Marcin¹, Yan, Yibing¹, Humke, Eric¹, Ebens, Allen¹, Hampton, Garret¹, Lackner, Mark R.¹, Hegde, Priti¹ hegde.priti@gene.com, Shidong Jia¹ jia.shidong@gene.com
Source:	Journal of Translational Medicine. 2013, Vol. 11 Issue 1, Special section p1-9. 9p. 1 Chart, 4 Graphs.
Database:	Academic Search Ultimate

Description
ISSN:	14795876
DOI:	10.1186/1479-5876-11-76